Description
BPC-157 + TB-500 Blend (5mg/5mg) — synergistic tissue repair stack for research in Australia. University-verified ≥99% purity. Same-day Sydney dispatch.
This blend combines BPC-157 with TB-500 (Thymosin Beta-4 fragment) in a precise 1:1 ratio. Both peptides have been extensively studied individually for tissue repair properties, and this combination allows investigation of potential synergistic mechanisms.
What the Research Shows
BPC-157 research focuses on VEGFR2 pathway activation and nitric oxide modulation, while TB-500 studies examine actin polymerisation and cell migration through the LKKTETQ motif.
Combined administration allows researchers to investigate whether distinct mechanisms produce additive or synergistic effects on tissue repair processes, angiogenesis, and inflammatory modulation.
Why Australian Researchers Choose Purpose Labs
Every batch is tested at a leading Australian university — HPLC and mass spectrometry confirm ≥99% purity for both components. No generic overseas certificates.
→ Full BPC-157 + TB-500 Blend 10mg (5mg/5mg) Research Guide
Purity: ≥99% each component (HPLC)
Form: Lyophilised powder
BPC-157: 5mg
TB-500: 5mg
Total: 10mg
Research: PubMed
▸ Australian university verified
▸ ≥99% purity both components
▸ Same-day dispatch from Sydney
▸ Accurate 1:1 ratio
Related Research and Resources
For research use only. Not for human consumption.




